Wolverine Trading, LLC Biocryst Pharmaceuticals Inc Put Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Put Options

25 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$6.41 - $8.69 $641 - $869	100 Added 0.33%	30,100 $228,000
Q2 2024 Aug 14, 2024	BUY	$4.13 - $6.79 $78,057 - $128,331	18,900 Added 170.27%	30,000 $185,000
Q1 2024 May 15, 2024	SELL	$4.89 - $7.65 $52,812 - $82,620	-10,800 Reduced 49.32%	11,100 $56,000
Q4 2023 Feb 14, 2024	BUY	$4.98 - $6.77 $49,302 - $67,023	9,900 Added 82.5%	21,900 $131,000
Q3 2023 Nov 15, 2023	SELL	$6.71 - $7.92 $26,840 - $31,680	-4,000 Reduced 25.0%	12,000 $84,000
Q2 2023 Aug 23, 2023	SELL	$6.96 - $8.81 $63,336 - $80,171	-9,100 Reduced 36.25%	16,000 $112,000
Q1 2023 May 15, 2023	BUY	$7.94 - $11.84 $199,294 - $297,184	25,100 New	25,100 $211,000
Q3 2022 Nov 14, 2022	BUY	$10.79 - $14.81 $11,868 - $16,291	1,100 Added 2.0%	56,200 $695,000
Q2 2022 Aug 15, 2022	SELL	$7.89 - $17.88 $153,855 - $348,660	-19,500 Reduced 26.14%	55,100 $596,000
Q1 2022 May 16, 2022	BUY	$11.56 - $19.76 $862,376 - $1.47 Million	74,600 New	74,600 $1.23 Million
Q4 2021 Feb 14, 2022	SELL	$11.18 - $15.46 $1.08 Million - $1.49 Million	-96,600 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$14.21 - $17.65 $319,725 - $397,124	-22,500 Reduced 18.89%	96,600 $1.39 Million
Q2 2021 Aug 06, 2021	BUY	$9.5 - $17.24 $503,500 - $913,719	53,000 Added 80.18%	119,100 $1.85 Million
Q1 2021 May 14, 2021	BUY	$7.37 - $13.61 $51,590 - $95,270	7,000 Added 11.84%	66,100 $660,000
Q4 2020 Feb 12, 2021	BUY	$3.37 - $8.61 $39,092 - $99,876	11,600 Added 24.42%	59,100 $443,000
Q3 2020 Nov 13, 2020	BUY	$3.43 - $5.53 $54,537 - $87,927	15,900 Added 50.32%	47,500 $182,000
Q2 2020 Aug 13, 2020	BUY	$1.9 - $5.61 $2,470 - $7,293	1,300 Added 4.29%	31,600 $157,000
Q1 2020 May 11, 2020	SELL	$1.6 - $4.11 $4,480 - $11,508	-2,800 Reduced 8.46%	30,300 $60,000
Q4 2019 Feb 12, 2020	SELL	$1.59 - $3.45 $68,688 - $149,040	-43,200 Reduced 56.62%	33,100 $107,000
Q2 2019 Aug 20, 2019	BUY	$2.91 - $9.15 $222,033 - $698,145	76,300 New	76,300 $289,000
Q1 2019 May 15, 2019	SELL	$7.38 - $9.72 $174,168 - $229,392	-23,600 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$6.51 - $9.6 $35,154 - $51,840	5,400 Added 29.67%	23,600 $186,000
Q3 2018 Nov 14, 2018	BUY	$5.52 - $7.99 $100,463 - $145,418	18,200 New	18,200 $139,000
Q4 2017 Feb 14, 2018	SELL	$4.16 - $5.33 $268,320 - $343,785	-64,500 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$4.1 - $5.97 $264,450 - $385,065	64,500	64,500 $338,000

Others Institutions Holding BCRX

# of Institutions

278

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

Vanguard Group Inc Valley Forge, PA

20.3M
Shares

$156 Million
0.0% of portfolio
Black Rock Inc. New York, NY

20M
Shares

$153 Million
0.0% of portfolio
Avoro Capital Advisors LLC New York, NY

11.9M
Shares

$91 Million
1.36% of portfolio
Kynam Capital Management, LP Princeton, NJ

9.09M
Shares

$69.7 Million
5.66% of portfolio
State Street Corp Boston, MA

8.85M
Shares

$67.9 Million
0.0% of portfolio

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.43B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account